Loss of MAP3K7 sensitizes prostate cancer cells to CDK1/2 inhibition and DNA damage by disrupting homologous recombination
Washino, Satoshi, Rider, Leah C., Romero, Lina, Jillson, Lauren K, Affandi, Trisiani, Ohm, Angela M, Lam, Elaine T, Reyland, Mary E., Costello, James C, Cramer, Scott DJournal:
Molecular Cancer Research
DOI:
10.1158/1541-7786.MCR-18-1335
Date:
July, 2019
Fichier:
PDF, 5.35 MB
2019
File converter
Plus de résultats de recherche
More benefits 
